Einar Stefánsson

Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland.

Risk ehf. provide healthcare services. The firm offer services to optometrists, ophthalmologists, primary care physicians, diabetes services. The company was founded by Enar Stefánsson and Arna Guomundsdóttir in 2009 and is headquartered in Reykjavík, Iceland.

Oxymap ehf develops innovative medical devices and software for ophthalmology. Its specializes medical devices, health technology, ophthalmology, research and development, pharmaceuticals, healthcare, blindness and diabetes. The company was founded by in 2002 and is headquartered in Reykjavík, Iceland.

Oxymap ehf develops innovative medical devices and software for ophthalmology. Its specializes medical devices, health technology, ophthalmology, research and development, pharmaceuticals, healthcare, blindness and diabetes. The company was founded by in 2002 and is headquartered in Reykjavík, Iceland.

Oxymap ehf develops innovative medical devices and software for ophthalmology. Its specializes medical devices, health technology, ophthalmology, research and development, pharmaceuticals, healthcare, blindness and diabetes. The company was founded by in 2002 and is headquartered in Reykjavík, Iceland.